[A controlled clinical study on the efficacy and tolerability of stepronin in chronic alcoholic liver diseases].
A group of 15 hospitalized chronic alcoholics was treated for 30 days with twice daily doses of 840 mg stepronin and was compared to 15 patients receiving placebo. The favorable results of this treatment are reported together with statistically significant changes of laboratory tests.